ExodusPoint Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-33,984	Closed	-$669K	–	1512
2025 Q1	$669K	Buy	33,984 +25,084	+282%	+$494K	0.01%	980
2024 Q4	$200K	Buy	+8,900	New	+$200K	﹤0.01%	1249
2020 Q2	–	Sell	-4,957	Closed	-$318K	–	1800
2020 Q1	$318K	Buy	+4,957	New	+$318K	0.02%	595